MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1126/scitranslmed.3003877

Медицинская библиотека · Science translational medicine · 2012

Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression.

Lauring Brett, Taggart Andrew K P, Tata James R, Dunbar Richard, Caro Luzelena, Cheng Kang, Chin Jayne, Colletti Steven L, Cote Josee, Khalilieh Sauzanne, Liu Jiajun, Luo Wen-Lin, Maclean Alexandra A, Peterson Laurence B, Polis Adam B, Sirah Waheeda, Wu Tsuei-Ju, Liu Xuan, Jin Lan, Wu Kenneth, Boatman P Douglas, Semple Graeme, Behan Dominic P, Connolly Daniel T, Lai Eseng, Wagner John A, Wright Samuel D, Cuffie Cynthia, Mitchel Yale B, Rader Daniel J, Paolini John F, Waters M Gerard, Plump Andrew

Клиническое исследование II фазыСтатьяРандомизированное исследованиеПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Nicotinic acid (niacin) induces beneficial changes in serum lipoproteins and has been associated with beneficial cardiovascular effects. Niacin reduces low-density lipoprotein, increases high-density lipoprotein, and decreases triglycerides. It is well established that activation of the seven-transmembrane G(i)-coupled receptor GPR109A on Langerhans cells results in release of prostaglandin D₂, which mediates the well-known flushing side effect of niacin. Niacin activation of GPR109A on adipocytes also mediates the transient reduction of plasma free fatty acid (FFA) levels characteristic of niacin, which has been long hypothesized to be the mechanism underlying the changes in the serum lipid profile. We tested this "FFA hypothesis" and the hypothesis that niacin lipid efficacy is mediated via GPR109A by dosing mice lacking GPR109A with niacin and testing two novel, full GPR109A agonists, MK-1903 and SCH900271, in three human clinical trials. In mice, the absence of GPR109A had no effect on niacin's lipid efficacy despite complete abrogation of the anti-lipolytic effect. Both MK-1903 and SCH900271 lowered FFAs acutely in humans; however, neither had the expected effects on serum lipids. Chronic FFA suppression was not sustainable via GPR109A agonism with niacin, MK-1903, or SCH900271. We conclude that the GPR109A receptor does not mediate niacin's lipid efficacy, challenging the long-standing FFA hypothesis.

Для цитирования: Lauring Brett, Taggart Andrew K P, Tata James R, Dunbar Richard, Caro Luzelena, Cheng Kang, Chin Jayne, Colletti Steven L, Cote Josee, Khalilieh Sauzanne, Liu Jiajun, Luo Wen-Lin, Maclean Alexandra A, Peterson Laurence B, Polis Adam B, Sirah Waheeda, Wu Tsuei-Ju, Liu Xuan, Jin Lan, Wu Kenneth, Boatman P Douglas, Semple Graeme, Behan Dominic P, Connolly Daniel T, Lai Eseng, Wagner John A, Wright Samuel D, Cuffie Cynthia, Mitchel Yale B, Rader Daniel J, Paolini John F, Waters M Gerard, Plump Andrew. Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression.. Science translational medicine. 2012. DOI: 10.1126/scitranslmed.3003877.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.